JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IBDP
5876
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $6K | ﹤0.01% |
245
| – | – |
2019 Q4
12 quarters
|
|
|
EVLO
5877
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $6K | ﹤0.01% |
177
-183
| -51% | -$7.24K |
2018 Q2
18 quarters
|
|
|
NVCN
5878
DELISTED
Neovasc Inc.
NVCN
| $6K | ﹤0.01% |
399
-300
| -43% | -$2.46K |
2019 Q2
14 quarters
|
|
|
JSD
5879
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
| $6K | ﹤0.01% |
522
+98
| +23% | +$1.17K |
2014 Q4
32 quarters
|
|
|
ABX
5880
Abacus Global Management
ABX
$803M
| $5K | ﹤0.01% |
448
| – | – |
2022 Q2
2 quarters
|
|
5881
ALPS Clean Energy ETF
ACES
$98.8M
| $5K | ﹤0.01% |
+87
| New | +$4.55K |
2022 Q4
0 quarters
|
|
5882
Innovator US Equity Buffer ETF August
BAUG
$273M
| $5K | ﹤0.01% |
+155
| New | +$4.64K |
2022 Q4
0 quarters
|
|
5883
CALL
Cleveland-Cliffs
CLF
$6.87B
| $5K | ﹤0.01% |
+300
| New | +$4.52K |
2022 Q4
0 quarters
|
|
5884
Corbus Pharmaceuticals
CRBP
$115M
| $5K | ﹤0.01% |
1,447
-19
| -1% | -$73 |
2017 Q4
20 quarters
|
|
|
HELP
5885
Helus Pharma Inc. Common Stock
HELP
$843M
| $5K | ﹤0.01% |
474
+53
| +13% | +$874 |
2022 Q2
2 quarters
|
|
|
ESSA
5886
DELISTED
ESSA Bancorp
ESSA
| $5K | ﹤0.01% |
228
-1,517
| -87% | -$30.9K |
2017 Q4
20 quarters
|
|
5887
Global Indemnity Group
GBLI
$354M
| $5K | ﹤0.01% |
233
+229
| +5,725% | +$5.32K |
2013 Q2
38 quarters
|
|
5888
iShares Currency Hedged MSCI Japan ETF
HEWJ
$666M
| $5K | ﹤0.01% |
190
-734,119
| -100% | -$25.9M |
2015 Q1
31 quarters
|
|
|
HGLB
5889
Highland Global Allocation Fund
HGLB
$156M
| $5K | ﹤0.01% |
+571
| New | +$5.39K |
2022 Q4
0 quarters
|
|
5890
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.08B
| $5K | ﹤0.01% |
145
+125
| +625% | +$4.73K |
2022 Q3
1 quarter
|
|
5891
Invesco Value Municipal Income Trust
IIM
$504M
| $5K | ﹤0.01% |
+398
| New | +$4.65K |
2022 Q4
0 quarters
|
|
5892
Immuneering
IMRX
$263M
| $5K | ﹤0.01% |
960
-183
| -16% | -$1.62K |
2021 Q3
5 quarters
|
|
5893
iShares S&P India Nifty 50 Index Fund
INDY
$495M
| $5K | ﹤0.01% |
114
| – | – |
2017 Q2
22 quarters
|
|
|
IRBT
5894
PUT
DELISTED
iRobot
IRBT
| $5K | ﹤0.01% |
+100
| New | +$5.29K |
2022 Q4
0 quarters
|
|
5895
Kopin
KOPN
$898M
| $5K | ﹤0.01% |
4,299
-51,489
| -92% | -$63.7K |
2021 Q2
6 quarters
|
|
|
MAXN
5896
CALL
DELISTED
Maxeon Solar Technologies
MAXN
| $5K | ﹤0.01% |
3
| – | – |
2022 Q1
3 quarters
|
|
5897
Natural Health Trends
NHTC
$8.36M
| $5K | ﹤0.01% |
1,451
-4,176
| -74% | -$15.9K |
2017 Q4
20 quarters
|
|
5898
Navios Maritime Partners
NMM
$2.7B
| $5K | ﹤0.01% |
180
| – | – |
2021 Q1
7 quarters
|
|
5899
AXS Green Alpha ETF
NXTE
$57.4M
| $5K | ﹤0.01% |
+158
| New | +$4.85K |
2022 Q4
0 quarters
|
|
5900
Owlet
OWLT
$153M
| $5K | ﹤0.01% |
666
+37
| +6% | +$460 |
2021 Q3
5 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.